Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
21 participants
INTERVENTIONAL
2003-09-30
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Pectoral Nerve Block on Post-op Pain in Patients Undergoing Mastectomy and Immediate Reconstruction
NCT02913573
Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks
NCT01231204
Cryoablation for Post Mastectomy Pain Syndrome
NCT03293940
Nerveblocks for Persistent Pain After Breast Cancer Surgery
NCT02336529
Shoulder Denervation for Post Mastectomy Irradiation Shoulder Pain
NCT07095569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lidocaine Patch
Drug: lidocaine patch 5% (Lidoderm®, Endo Pharmaceuticals Inc.), 1 patch was applied topically to the affected site(s) for 12 hours each day.
Lidoderm patch
1 patch was applied topically to the affected site(s) for 12 hours each day.
Placebo Patch
Drug: placebo patch, 1 patch was applied topically to the affected site(s) for 12 hours each day.
Placebo patch
1 patch was applied topically to the affected site(s) for 12 hours each day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidoderm patch
1 patch was applied topically to the affected site(s) for 12 hours each day.
Placebo patch
1 patch was applied topically to the affected site(s) for 12 hours each day.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has a healed incision(s)
* Has no recurrent disease in the painful area
* Is able to read, write and understand English
Exclusion Criteria
* Use of an opioid analgesic of greater than 60 mg codeine/day
* Is actively trying to become pregnant
* Has a medical contraindication to the use of lidocaine
* Has an allergy to lidocaine
* Is taking a coanalgesic for neuropathic pain.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCSF Comprehensive Cancer Center
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CA107091
Identifier Type: -
Identifier Source: secondary_id
Breast Pain
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.